Comparison of Survival Outcomes in Node-Negative T1a and T1b High-risk Breast Cancer Treated with and without Adjuvant Chemotherapy

被引：0
|
作者：
Carlson, K. A. [1 ]
Thompson, C. K. [1 ]
Siegel, E. L. [1 ]
Kim, S. [1 ]
Bao, J. J. [2 ]
Amersi, F. [1 ]
Giuliano, A. [1 ]
Chung, A. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Surg, Los Angeles, CA 90048 USA
[2] Univ Chicago, Chicago, IL 60637 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PT50
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [1] Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer
    Fasano, Genevieve A.
    Bayard, Solange
    Chen, Yalei
    Varella, Leticia
    Cigler, Tessa
    Bensenhaver, Jessica
    Simmons, Rache
    Swistel, Alexander
    Marti, Jennifer
    Moore, Anne
    Andreopoulou, Eleni
    Ng, John
    Brandmaier, Andrew
    Formenti, Silvia
    Ali, Haythem
    Davis, Melissa
    Newman, Lisa
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 192 (01) : 163 - 173
  • [2] Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer
    Genevieve A. Fasano
    Solange Bayard
    Yalei Chen
    Leticia Varella
    Tessa Cigler
    Jessica Bensenhaver
    Rache Simmons
    Alexander Swistel
    Jennifer Marti
    Anne Moore
    Eleni Andreopoulou
    John Ng
    Andrew Brandmaier
    Silvia Formenti
    Haythem Ali
    Melissa Davis
    Lisa Newman
    Breast Cancer Research and Treatment, 2022, 192 : 163 - 173
  • [3] Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer
    Carbajal-Ochoa, Walter
    Bravo-Solarte, Daniela C.
    Bernal, Ana M.
    Anampa, Jesus D.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (02) : 257 - 269
  • [4] Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer
    Walter Carbajal-Ochoa
    Daniela C. Bravo-Solarte
    Ana M. Bernal
    Jesus D. Anampa
    Breast Cancer Research and Treatment, 2024, 203 : 257 - 269
  • [5] The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer
    Johnson, Kai C. C.
    Ni, Ai
    Quiroga, Dionisia
    Pariser, Ashley C.
    Sudheendra, Preeti K.
    Williams, Nicole O.
    Sardesai, Sagar D.
    Cherian, Mathew
    Stover, Daniel G.
    Gatti-Mays, Margaret
    Ramaswamy, Bhuvaneswari
    Lustberg, Maryam
    Jhawar, Sachin
    Skoracki, Roman
    Wesolowski, Robert
    NPJ BREAST CANCER, 2024, 10 (01)
  • [6] Adjuvant chemotherapy outcomes of node negative, T1a, T1b, T1c hormone receptor-negative HER2-positive breast cancer patients
    Paul, Anu
    Shi, Runhua
    Peddi, Prakash
    Burton, Gary
    CANCER RESEARCH, 2017, 77
  • [7] Axillary lymph node dissection in T1a and T1b breast cancer
    Fancellu, A
    Cottu, P
    Porcu, A
    Castiglia, P
    Lorettu, A
    Mura, I
    Giuliani, G
    Contini, AM
    Dettori, G
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S106 - S106
  • [8] Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
    G. Cancello
    P. Maisonneuve
    N. Rotmensz
    G. Viale
    M. G. Mastropasqua
    G. Pruneri
    E. Montagna
    S. Dellapasqua
    M. Iorfida
    A. Cardillo
    P. Veronesi
    A. Luini
    M. Intra
    O. Gentilini
    E. Scarano
    A. Goldhirsch
    M. Colleoni
    Breast Cancer Research and Treatment, 2011, 127
  • [9] Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
    Cancello, G.
    Maisonneuve, P.
    Rotmensz, N.
    Viale, G.
    Mastropasqua, M. G.
    Pruneri, G.
    Montagna, E.
    Dellapasqua, S.
    Iorfida, M.
    Cardillo, A.
    Veronesi, P.
    Luini, A.
    Intra, M.
    Gentilini, O.
    Scarano, E.
    Goldhirsch, A.
    Colleoni, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (03) : 713 - 720
  • [10] Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
    Cancello, G.
    Maisonneuve, P.
    Rotmensz, N.
    Viale, G.
    Mastropasqua, M. G.
    Pruneri, G.
    Montagna, E.
    Dellapasqua, S.
    Iorfida, M.
    Cardillo, A.
    Veronesi, P.
    Luini, A.
    Intra, M.
    Gentilini, O. D.
    Scarano, E.
    Pastrello, D.
    Goldhirsch, A.
    Colleoni, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345